4//SEC Filing
Gentry Leesa 4
Accession 0001493152-24-009409
CIK 0001574094other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:28 PM ET
Size
5.4 KB
Accession
0001493152-24-009409
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Gentry Leesa
Chief Clinical Officer
Transactions
- Award
Options
2024-03-06+190,000→ 190,000 totalExercise: $1.69→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]Represents 10-year incentive stock options to purchase 190,000 shares of the Company's common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. These options vest over four years at a rate of 1/48 per month, beginning to vest on March 1, 2024.
Documents
Issuer
RenovoRx, Inc.
CIK 0001574094
Entity typeother
Related Parties
1- filerCIK 0002013097
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:28 PM ET
- Size
- 5.4 KB